Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome
about
sameAs
Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profilesWhy the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkersStromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines.Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells.Inflammatory and microenvironmental factors involved in breast cancer progression.Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases-1 in the prognostic evaluation of primary breast cancer patients.Diagnostic and prognostic relevance of MMP-11 expression in the stromal fibroblast-like cells adjacent to invasive ductal carcinoma of the breast.Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.
P2860
Q21261300-2DAC55CA-DCA1-4407-B7D7-630A5A7C90CEQ27023385-C262C8AC-5A83-4435-B218-32DA2E1669BBQ33269607-A56BB183-8D15-44B6-9B3A-4B0825380AD5Q34550978-A2252895-3882-4361-A43B-EE747AF59106Q34836999-77D3A040-9A55-41D6-BFCE-ECFADFBA4237Q36611308-840D6DD6-F084-4E5E-BC3E-D8DAFAAB5E96Q36694087-458F5AF6-9244-4205-9CC8-937B47F99528Q37140849-287E3256-887C-458D-9BAF-5872E70E02FDQ37295578-9BD8C0BD-0B60-43E2-99CD-AAD1CCD21F81Q38162168-5F61ED47-C195-4998-AF5D-5DA5B1C421BDQ39141096-1CC666AF-4569-480D-9AB4-A6D3C2B3E588Q39503945-E9139732-C54D-420F-9A9C-D4F2D35C1854Q43432288-6F2E911A-C4B8-4557-AF21-696AE22A02FFQ44891886-821FD8C3-E3D6-4A6F-947D-00F75A7C7315Q47925738-332A2EE0-145E-4D8C-B87A-49C90AF30BA6
P2860
Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Stromelysin-3 protein expressi ...... survival and patients' outcome
@ast
Stromelysin-3 protein expressi ...... survival and patients' outcome
@en
Stromelysin-3 protein expressi ...... survival and patients' outcome
@nl
type
label
Stromelysin-3 protein expressi ...... survival and patients' outcome
@ast
Stromelysin-3 protein expressi ...... survival and patients' outcome
@en
Stromelysin-3 protein expressi ...... survival and patients' outcome
@nl
prefLabel
Stromelysin-3 protein expressi ...... survival and patients' outcome
@ast
Stromelysin-3 protein expressi ...... survival and patients' outcome
@en
Stromelysin-3 protein expressi ...... survival and patients' outcome
@nl
P2093
P3181
P1433
P1476
Stromelysin-3 protein expressi ...... survival and patients' outcome
@en
P2093
Antonios Keramopoulos
Effie G Panayotopoulou
Ioanna Giannopoulou
Lydia Nakopoulou
Paraskevi Alexandrou
Pauline Athanassiadou
Sophia Katsarou
P304
P3181
P356
10.1097/01.MP.0000037317.84782.CD
P407
P577
2002-11-01T00:00:00Z
P6179
1002979903